Home Compliance Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to... ComplianceFCANews Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians July 10, 2020 143 Share FacebookLinkedinTwitter Soru Epotok | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator Can’t Escape First-To-File Rule By Amending Complaint Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute Compliance A Guide for Whistleblowers Under the False Claims Act